A detailed history of Jump Financial, LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Jump Financial, LLC holds 200,200 shares of BCRX stock, worth $1.69 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
200,200
Holding current value
$1.69 Million
% of portfolio
0.03%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$4.13 - $6.79 $826,826 - $1.36 Million
200,200 New
200,200 $1.24 Million
Q4 2023

Oct 21, 2024

SELL
$4.98 - $6.77 $1.38 Million - $1.87 Million
-276,142 Reduced 68.2%
128,771 $771,000
Q4 2023

Feb 07, 2024

SELL
$4.98 - $6.77 $1.38 Million - $1.87 Million
-276,142 Reduced 68.2%
128,771 $771,000
Q3 2023

Oct 21, 2024

BUY
$6.71 - $7.92 $2.14 Million - $2.53 Million
319,037 Added 371.51%
404,913 $2.87 Million
Q3 2023

Nov 07, 2023

BUY
$6.71 - $7.92 $2.14 Million - $2.53 Million
319,037 Added 371.51%
404,913 $2.87 Million
Q2 2023

Oct 21, 2024

SELL
$6.96 - $8.81 $1.58 Million - $2.01 Million
-227,665 Reduced 72.61%
85,876 $604,000
Q2 2023

Aug 07, 2023

SELL
$6.96 - $8.81 $1.58 Million - $2.01 Million
-227,665 Reduced 72.61%
85,876 $604,000
Q1 2023

Oct 21, 2024

BUY
$7.94 - $11.84 $899,927 - $1.34 Million
113,341 Added 56.61%
313,541 $2.61 Million
Q1 2023

May 03, 2023

BUY
$7.94 - $11.84 $2.49 Million - $3.71 Million
313,541 New
313,541 $2.61 Million
Q1 2022

May 12, 2022

SELL
$11.56 - $19.76 $384,948 - $658,008
-33,300 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$11.18 - $15.46 $372,294 - $514,818
33,300 New
33,300 $461,000
Q2 2021

Aug 13, 2021

SELL
$9.5 - $17.24 $181,497 - $329,370
-19,105 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$7.37 - $13.61 $140,803 - $260,019
19,105 New
19,105 $194,000
Q4 2020

Feb 12, 2021

SELL
$3.37 - $8.61 $644,623 - $1.65 Million
-191,283 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$3.43 - $5.53 $656,100 - $1.06 Million
191,283 New
191,283 $657,000

Others Institutions Holding BCRX

About BIOCRYST PHARMACEUTICALS INC


  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.57B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.